Glucagonoma MRI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Glucagonoma}} | {{Glucagonoma}} | ||
{{CMG}}{{AE}}{{PSD}} | {{CMG}}; {{AE}} {{PSD}} {{MAD}} | ||
==Overview== | ==Overview== | ||
| Line 8: | Line 8: | ||
==MRI== | ==MRI== | ||
*Findings on abdominal MRI suggestive of glucagonoma include:<ref name="pmid25789004" /> | *Findings on abdominal MRI suggestive of glucagonoma include:<ref name="pmid25789004" /> | ||
*T1: low signal intensity | **T1: low signal intensity | ||
*T2: high signal intensity | **T2: high signal intensity | ||
*MRI is preferred over contrast-enhanced CT or somatostatin receptor scintigraphy for assessing metastasis. 49 50 | *MRI is preferred over contrast-enhanced CT or somatostatin receptor scintigraphy for assessing metastasis. 49 50 | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 17:23, 1 August 2017
|
Glucagonoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Glucagonoma MRI On the Web |
|
American Roentgen Ray Society Images of Glucagonoma MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2] Mohammed Abdelwahed M.D[3]
Overview
Abdominal MRI is helpful in the diagnosis of glucagonoma. On abdominal MRI, glucagonoma is characterized by a mass which is hypointense on T1-weighted MRI and hyperintense on T2-weighted MRI.[1]
MRI
- Findings on abdominal MRI suggestive of glucagonoma include:[1]
- T1: low signal intensity
- T2: high signal intensity
- MRI is preferred over contrast-enhanced CT or somatostatin receptor scintigraphy for assessing metastasis. 49 50
References
- ↑ 1.0 1.1 Lv WF, Han JK, Liu X, Wang SC, Pan BO, Xu AO (2015). "Imaging features of glucagonoma syndrome: A case report and review of the literature". Oncol Lett. 9 (4): 1579–1582. doi:10.3892/ol.2015.2930. PMC 4356379. PMID 25789004.